These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 8566261)

  • 1. The effects of hormone replacement therapy on uterine fibroids in postmenopausal women.
    Sener AB; Seçkin NC; Ozmen S; Gökmen O; Doğu N; Ekici E
    Fertil Steril; 1996 Feb; 65(2):354-7. PubMed ID: 8566261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The effects of menopausal replacement therapy in women with uterine myomas].
    Orsini G; Pinto V; Di Biase S; D'Altorio C; Lanzilotti G
    Minerva Ginecol; 1999 Nov; 51(11):421-5. PubMed ID: 10726441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Impact of Hormonal Replacement Treatment in Postmenopausal Women with Uterine Fibroids: A State-of-the-Art Review of the Literature.
    Moro E; Degli Esposti E; Borghese G; Manzara F; Zanello M; Raimondo D; Gava G; Arena A; Casadio P; Meriggiola MC; Seracchioli R
    Medicina (Kaunas); 2019 Aug; 55(9):. PubMed ID: 31480288
    [No Abstract]   [Full Text] [Related]  

  • 4. Transdermal hormone replacement therapy in postmenopausal women with uterine leiomyomas.
    Palomba S; Sena T; Noia R; Di Carlo C; Zullo F; Mastrantonio P
    Obstet Gynecol; 2001 Dec; 98(6):1053-8. PubMed ID: 11755553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of different doses of progestin on uterine leiomyomas in postmenopausal women.
    Palomba S; Sena T; Morelli M; Noia R; Zullo F; Mastrantonio P
    Eur J Obstet Gynecol Reprod Biol; 2002 May; 102(2):199-201. PubMed ID: 11950491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized study of the effects of tibolone and transdermal estrogen replacement therapy in postmenopausal women with uterine myomas.
    Fedele L; Bianchi S; Raffaelli R; Zanconato G
    Eur J Obstet Gynecol Reprod Biol; 2000 Jan; 88(1):91-4. PubMed ID: 10659924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uterine findings by transvaginal sonography during percutaneous estrogen treatment in postmenopausal women.
    Ylöstalo P; Granberg S; Bäckström AC; Hirsjärvi-Lahti T
    Maturitas; 1996 Apr; 23(3):313-7. PubMed ID: 8794426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of hormone replacement therapy on uterine fibroids in postmenopausal women--a 3-year study.
    Yang CH; Lee JN; Hsu SC; Kuo CH; Tsai EM
    Maturitas; 2002 Sep; 43(1):35-9. PubMed ID: 12270580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effects of hormone-replacement therapy on endogenous nitric oxide (nitrite/nitrate) levels in postmenopausal women substituted with 17 beta-estradiol valerate and cyproterone acetate or medroxyprogesterone acetate.
    Imthurn B; Rosselli M; Jaeger AW; Keller PJ; Dubey RK
    J Clin Endocrinol Metab; 1997 Feb; 82(2):388-94. PubMed ID: 9024224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of different hormone replacement therapy regimens on the size of myoma uteri in postmenopausal period: tibolone versus transdermal hormonal replacement system.
    Simsek T; Karakus C; Trak B
    Maturitas; 2002 Jul; 42(3):243-6. PubMed ID: 12161049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects on haemostasis of hormone replacement therapy with transdermal estradiol and oral sequential medroxyprogesterone acetate: a 1-year, double-blind, placebo-controlled study. The Writing Group for the Estradiol Clotting Factors Study.
    Thromb Haemost; 1996 Mar; 75(3):476-80. PubMed ID: 8701411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hormone therapy in menopausal women with fibroids: is it safe?
    Srinivasan V; Martens MG
    Menopause; 2018 Aug; 25(8):930-936. PubMed ID: 29613885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological effects of hormone replacement therapy in relation to serum estradiol levels.
    Yasui T; Uemura H; Tezuka M; Yamada M; Irahara M; Miura M; Aono T
    Horm Res; 2001; 56(1-2):38-44. PubMed ID: 11815726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Add-back therapy for long-term use in dysfunctional uterine bleeding and uterine fibroids.
    Thomas EJ
    Br J Obstet Gynaecol; 1996 Oct; 103 Suppl 14():18-21. PubMed ID: 8916983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum estrogen level after hormone replacement therapy and body mass index in postmenopausal and bilaterally ovariectomized women.
    Yasui T; Uemura H; Umino Y; Takikawa M; Saito S; Kuwahara A; Matsuzaki T; Maegawa M; Furumoto H; Miura M; Irahara M
    Maturitas; 2005 Jan; 50(1):19-29. PubMed ID: 15590210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of hormone replacement therapy on postmenopausal uterine myoma.
    Colacurci N; De Franciscis P; Cobellis L; Nazzaro G; De Placido G
    Maturitas; 2000 May; 35(2):167-73. PubMed ID: 10924843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of postmenopausal hormone replacement therapy on body fat composition.
    Yüksel H; Odabasi AR; Demircan S; Köseoğlu K; Kizilkaya K; Onur E
    Gynecol Endocrinol; 2007 Feb; 23(2):99-104. PubMed ID: 17454160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of continuation of postmenopausal hormone replacement therapy: transdermal versus oral estrogen.
    Ettinger B; Pressman A; Bradley C
    Menopause; 1998; 5(3):152-6. PubMed ID: 9774760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The route of administration influences the effect of estrogen on insulin sensitivity in postmenopausal women.
    Lindheim SR; Duffy DM; Kojima T; Vijod MA; Stanczyk FZ; Lobo RA
    Fertil Steril; 1994 Dec; 62(6):1176-80. PubMed ID: 7957980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uterine myoma in postmenopause: a comparison between two therapeutic schedules of HRT.
    Polatti F; Viazzo F; Colleoni R; Nappi RE
    Maturitas; 2000 Nov; 37(1):27-32. PubMed ID: 11099870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.